Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by robertshawon Jan 13, 2019 9:53am

113 Views

Post# 29224621

RE:Target price for TLT ?

pennyoilking wrote: If management can get its act together it’s $2,000.00 per share US for a short term hostile takeover!

Completely agree with you. Just one PR to the whole world 's pharmaceutical companies to bid the partnership in exchange of 10% the company's stake, and the highest bidder will have the glory to get the offer, sparkle the worldwide JV fire instead of doing cheap PPs, we could easily see $100+/share very soon.

Bullboard Posts

Soma Gold poised to extend profitable track record